Anti-CD28 McAb Enhance Anti-tumor Activity of Tumor Specific Cytotoxic T Lymphocyte in Vitro and in Vivo

黄辉,俞红,郑振,熊思东,林云璐

DOI: https://doi.org/10.3969/j.issn.1672-8467.2000.05.003

2000-01-01

Abstract:Purpose To enhance anti tumor activity of α?CD3 McAb activated tumor specific cytotoxic T lymphocyte(CTL) by α?CD28 McAb in vitro and vivo for tumor adoptive immunotherapy. Methods Two different modles were applied to culture splenocytes from FBL?3 immunized mice:(1) activated by α?CD3 McAb for 48 h and then cultured in α?CD3 McAb plus 20 U/ml rIL?2(α?CD3+IL?2 group);(2) activated by α?CD3 McAb,α?CD28 McAb for 48 h and then cultured in α?CD3 McAb,α?CD28 McAb plus 20 U/ml rIL?2(α?CD3+α?CD28+IL?2 group).The proliferation ( 3H?TdR incorporation assay)and anti tumor activity(standard 4 h? 51 Cr release assay) of FBL?3 specific CTL were studied in both groups.On day 12,each bearing tumor mouse was transferred with 1×10 7 CTL by ip. Results 3H?TdR incorporation (cpm) in α?CD3+IL?2 group and α?CD3+α?CD28+IL?2 group were 8.36×10 4,1.31×10 5 respectively.On day 12,the anti tumor activities of both groups were 35.6% and 49.5% respectively (E/T=12.5/1).The CTL of α?CD3+IL?2 group and α?CD3+α?CD28+IL?2 group were transferred to bearing tumor mouse respectively.The lifespans of bearing tumor mouse were 16.7 d and 20.8 d respectively. Conclusions α?CD28 McAb can enhance antitumor activity of tumor specific CTL activated by α?CD3 McAb.